Olympus America

Press Center

New Urinary/CSF Protein Reagent Available from Olympus

Melville, N.Y. (June 22, 2003) - A new reagent designed to assess Urinary/CSF protein, aiding in the diagnosis and treatment of renal, cardiac and thyroid disease, is now available from Olympus. The reagent is optimized for use on Olympus AU400e, AU600, AU640e, AU2700 and AU5400 chemistry-immuno analyzers, offering unparalleled instrument-to-instrument reagent standardization.

The Olympus Urinary/CSF reagent is a colorimetric assay utilizing pyrogallol red to directly measure protein complex. This assay is linear from 4-200 mg/dL and exhibits excellent recovery performance in the presence of Bence Jones protein. The Olympus Urinary/CSF protein reagent is a liquid, ready-to-use formulation featuring 60-day on-board and 30-day calibration stability; a single calibrator is included in the reagent kit. Two convenient kit sizes are available.

The reagent is available now. For additional information about the Olympus reagent line, users can visit the web site at www.olympusamerica.com or call the Olympus Diagnostic Systems Group at 1-800-223-0125.

About Olympus Diagnostic Systems Group
Since 1981, Olympus Diagnostic Systems Group has provided innovative solutions that meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks and pharmaceutical labs. Offering the broadest standardized line of random access, chemistry-immuno analyzers and lab automation systems, Olympus' solutions save laboratories time, maximize productivity and deliver fast, reliable results.

About Olympus
Olympus Optical Co., Ltd., with its wholly owned subsidiaries, is a global leader in developing new technologies and designing, manufacturing and marketing optical-digital product solutions for health care and consumer segments. The company leverages R&D investment in technology and manufacturing processes across diverse business lines that include:

  • minimally invasive diagnostic and surgical endoscopes;
  • advanced clinical and research microscopes;
  • chemistry-immuno analyzers and lab automation systems; and
  • digital and film cameras, and digital voice recorders.
  • In the U. S. and Canada, Olympus America Inc. serves health care, scientific and commercial laboratory markets with integrated product solutions and financial and other service offerings and is the leading brand in gastrointestinal endoscopy and clinical and educational microscopes. The company's market-leading consumer camera products and services business spans North and South America. Olympus America Inc. works collaboratively with its customers and parent company to develop state-of-the-art products and services that are innovative, intelligent, and easy to use. For more information, visit www.olympusamerica.com.